Severe COVID-19 in Cardiopath Young Pregnant Patient without Vertical Transmission

Ana Paula Figueiredo de Montalvão França1,2, Danielly do Vale Pereira3, Elaine Valéria Rodrigues3

  • 1Biology of Infectious and Parasitic Agents Post-Graduate Program, Federal University of Pará, Belém 66075-110, PA, Brazil.

Viruses
|April 23, 2022
PubMed

Insights

This case report details a fatal COVID-19 infection in a young pregnant woman with heart disease. Despite severe illness, SARS-CoV-2 was not transmitted to her newborn.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Obstetrics & Gynecology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a global pandemic.
  • Comorbidities, such as heart disease, can complicate COVID-19 outcomes.
  • Pregnancy presents unique physiological challenges, potentially increasing risks during viral infections.

Purpose of the Study:

  • To report a fatal case of SARS-CoV-2 infection in a young pregnant woman with pre-existing heart disease.
  • To investigate the possibility of vertical transmission of SARS-CoV-2 from mother to neonate in a severe case.
  • To highlight the impact of comorbidities on the clinical course of COVID-19 in pregnancy.

Main Methods:

  • Case report of a 26-year-old pregnant woman (28 weeks gestation) presenting with severe respiratory distress.
  • Clinical assessment including history of heart disease and rheumatic fever.
  • Diagnostic testing for SARS-CoV-2 in both mother and neonate post-cesarean delivery.

Main Results:

  • The mother tested positive for SARS-CoV-2 and progressed to a fatal outcome.
  • The neonate tested negative for SARS-CoV-2, indicating no vertical transmission.
  • The case underscores the significant role of comorbidities in severe COVID-19 progression.

Conclusions:

  • SARS-CoV-2 infection can be fatal in young pregnant women, particularly those with underlying heart conditions.
  • No evidence of vertical transmission was observed in this severe maternal COVID-19 case.
  • Comorbidities significantly influence the clinical severity and prognosis of COVID-19 during pregnancy.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
53
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
73
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
41
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
42
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
56
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
48